Skip to main content
Have a personal or library account? Click to login

               VEGFA and KDR gene variants as potential markers of endurance performance and sports-related injuries: A systematic review Cover

VEGFA and KDR gene variants as potential markers of endurance performance and sports-related injuries: A systematic review

Open Access
|May 2026

References

  1. Ahmetov, I. I., Hakimullina, A. M., Popov, D. V., Lyubaeva, E. V., Missina, S. S., Vinogradova, O. L., Williams, A. G., & Rogozkin, V. A. (2009). Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes. European Journal of Applied Physiology, 107(1), 95–103. doi: 10.1007/s00421-009-1105-7.
  2. Ahmetov, I. I., Khakimullina, A. M., Popov, D. V., Missina, S. S., Vinogradova, O. L., & Rogozkin, V. A. (2008). Polymorphism of the vascular endothelial growth factor gene (VEGF) and aerobic performance in athletes. Human Physiology, 34(4), 477. doi: 10.1134/S0362119708040129.
  3. Aziz, A., Uddin, M. S., Millat, S., & Islam, M. S. (2022). Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis. Meta Gene, 31, 101017. doi: 10.1016/j.mgene.2022.101017.
  4. Baker, J. (2011). Do genes predict potential? Genetic factors and athletic success. In Talent identification and development in sport. Routledge.
  5. Balberova, O. V., Bykov, E. V., Sidorkina, E. G., Petrova, M. M., & Shnayder, N. A. (2022). Genetic biomarkers of cardiovascular and cerebrovascular reserves in athletes. Personalized Psychiatry and Neurology, 2(2), 2. doi: 10.52667/2712-9179-2022-2-2-3-27.
  6. Berardi, R., Brunelli, A., Pagliaretta, S., Paolucci, V., Conti, A., Goteri, G., Refai, M., Pompili, C., Marcantognini, G., Morgese, F., Ballatore, Z., Savini, A., De Lisa, M., Caramanti, M., Santoni, M., Zizzi, A., Piva, F., Mazzanti, P., Onofri, A., …, & Cascinu, S. (2015). Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy. Oncotarget, 6(22), 19305–19315. doi: 10.18632/oncotarget.4191.
  7. Bloor, C. M. (2005). Angiogenesis during exercise and training. Angiogenesis, 8(3), 263–271. doi: 10.1007/s10456-005-9013-x.
  8. Bonsignore, M. R., Morici, G., Riccioni, R., Huertas, A., Petrucci, E., Veca, M., Mariani, G., Bonanno, A., Chimenti, L., Gioia, M., Palange, P., & Testa, U. (2010). Hemopoietic and angiogenetic progenitors in healthy athletes: Different responses to endurance and maximal exercise. Journal of Applied Physiology, 109(1), 60–67. doi: 10.1152/japplphysiol.01344.2009.
  9. Buroker, N. E. (2014). VEGFA rSNPs, transcriptional factor binding sites and human disease. The Journal of Physiological Sciences, 64(1), 73–76. doi: 10.1007/s12576-013-0293-4.
  10. Buroker, N. (2015). VEGFA SNPs (rs34357231 & rs35569394), transcriptional factor binding sites and human disease. British Journal of Medicine and Medical Research, 10(12), 1–11. doi: 10.9734/BJMMR/2015/19777.
  11. Chen, Y., Dawes, P. T., & Mattey, D. L. (2012). Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: Differential effect of cigarette smoking. Cytokine, 58(3), 390–397. doi: 10.1016/j.cyto.2012.02.018.
  12. Cięszczyk, P., Willard, K., Gronek, P., Zmijewski, P., Trybek, G., Gronek, J., Weber-Rajek, M., Stastny, P., Petr, M., Lulińska-Kuklik, E., Ficek, K., Kemeryte-Riaubiene, E., Maculewicz, E., & September, A. V. (2017). Are genes encoding proteoglycans really associated with the risk of anterior cruciate ligament rupture? Biology of Sport, 34(2), 97–103. doi: 10.5114/biolsport.2017.64582.
  13. Di Stefano, A. L., Labussiere, M., Lombardi, G., Eoli, M., Bianchessi, D., Pasqualetti, F., Farina, P., Cuzzubbo, S., Gallego-Perez-Larraya, J., Boisselier, B., Ducray, F., Cheneau, C., Moglia, A., Finocchiaro, G., Marie, Y., Rahimian, A., Hoang-Xuan, K., Delattre, J. Y., Mokhtari, K., & Sanson, M. (2015). VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab. Journal of Neuro-Oncology, 121(3), 499–504. doi: 10.1007/s11060-014-1677-x.
  14. Eider, J., Leońska-Duniec, A., Maciejewska-Skrendo, A., Sawczuk, M., Ficek, K., Sawczyn, S., & Cieszczyk, P. (2013). The VEGFR2 gene His472Gln polymorphism in Polish endurance athletes. International Sportmed Journal, 14, 29–35.
  15. El Azzouzi, M., El Ahanidi, H., Hafidi Alaoui, C., Chaoui, I., Benbacer, L., Tetou, M., Hassan, I., Bensaid, M., Oukabli, M., Ameur, A., Al Bouzidi, A., Attaleb, M., & El Mzibri, M. (2023). The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer. Diagnostics, 13, 1471. doi: 10.3390/diagnostics13081471.
  16. Facemire, C. S., Nixon, A. B., Griffiths, R., Hurwitz, H., & Coffman, T. M. (2009). Vascular endothelial growth factor receptor 2 (VEGFR2) controls blood pressure by regulating nitric oxide synthase expression. Hypertension, 54(3), 652–658. doi: 10.1161/HYPERTENSIONAHA.109.129973.
  17. Feldmann, D. C., Rahim, M., Suijkerbuijk, M. A. M., Laguette, M. J. N., Cieszczyk, P., Ficek, K., Huminska-Lisowska, K., Häger, C. K., Stattin, E., Nilsson, K. G., Alvarez-Rumero, J., Eynon, N., Feller, J., Tirosh, O., Posthumus, M., Chimusa, E. R., Collins, M., & September, A. V. (2022). Investigation of multiple populations highlight VEGFA polymorphisms to modulate anterior cruciate ligament injury. Journal of Orthopaedic Research, 40(7), 1604–1612. doi: 10.1002/jor.25192.
  18. Ferreira, C. P., Silvino, V. O., Trevisano, R. G., de Moura, R. C., Almeida, S. S., & Pereira dos Santos, M. A. (2024). Influence of genetic polymorphism on sports talent performance versus non-athletes: A systematic review and meta-analysis. BMC Sports Science, Medicine and Rehabilitation, 16(1), 223. doi: 10.1186/s13102-024-01001-5.
  19. Hussain, N., Mumtaz, M., Adil, M., Nadeem, A. A., Sarwar, A., Aziz, T., Alharbi, M., Alshammari, A., Alasmari, A. F., & Alharbi, M. E. (2023). Investigation of VEGF (rs 699947) polymorphism in the progression of Rheumatoid Arthritis (RA) and in-silico nanoparticle drug delivery of potential phytochemicals to cure RA. Acta Biochimica Polonica, 70(3), 3. doi: 10.18388/abp.2020_6654.
  20. Juginović, A., Kekić, A., Aranza, I., Biloš, V., & Armanda, M. (2025). Next-generation approaches in sports medicine: The role of genetics, omics, and digital health in optimizing athlete performance and longevity – a narrative review. Life, 15(7), 1023. doi: 10.3390/life15071023.
  21. Karamysheva, A. F. (2008). Mechanisms of angiogenesis. Biochemistry (Moscow), 73(7), 751–762. doi: 10.1134/S0006297908070031.
  22. Kim, D. H., Xu, W., Kamel-Reid, S., Liu, X., Jung, C. W., Kim, S., & Lipton, J. H. (2010). Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy. Annals of Oncology, 21(6), 1179–1188. doi: 10.1093/annonc/mdp452.
  23. Kissane, R. W. P., & Egginton, S. (2019). Exercise-mediated angiogenesis. Current Opinion in Physiology, 10, 193–201. doi: 10.1016/j.cophys.2019.06.005.
  24. Komar, A. A. (2007). Silent SNPs: Impact on gene function and phenotype. Pharmacogenomics, 8(8), 1075–1080. doi: 10.2217/14622416.8.8.1075.
  25. Lin, M., Whitmire, S., Chen, J., Farrel, A., Shi, X., & Guo, J. (2017). Effects of short indels on protein structure and function in human genomes. Scientific Reports, 7(1), 9313. doi: 10.1038/s41598-017-09287-x.
  26. Liu, X., Zhu, B., Li, Y., Liu, X., Guo, S., Wang, C., Li, S., & Wang, D. (2021). The role of vascular endothelial growth factor in tendon healing. Frontiers in Physiology, 12, 766080. doi: 10.3389/fphys.2021.766080.
  27. Lulińska-Kuklik, E., Leźnicka, K., Humińska-Lisowska, K., Moska, W., Michałowska-Sawczyn, M., Ossowski, Z., Maculewicz, E., Cięszczyk, P., Kaczmarczyk, M., Ratkowski, W., Ficek, K., Zmijewski, P., & Leońska-Duniec, A. (2018). The VEGFA gene and anterior cruciate ligament rupture risk in the Caucasian population. Biology of Sport, 36(1), 3–8. doi: 10.5114/biolsport.2018.78902.
  28. Ma, W., Xin, K., Chen, K., Tang, H., Chen, H., Zhi, L., & Liu, H. (2018). Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study. Scientific Reports, 8(1), 16221. doi: 10.1038/s41598-018-34352-4.
  29. Melincovici, C. S., Bo, A. B., Mihu, C., Istrate, M., Moldovan, I. M., Roman, A. L., & Mihu, C. M. (2018). Vascular endothelial growth factor (VEGF) – key factor in normal and pathological angiogenesis. Romanian Journal of Morphology & Embryology, 59(2), 455–467.
  30. Metzger, C. S., Koutsimpelas, D., & Brieger, J. (2015). Transcriptional regulation of the VEGF gene in dependence of individual genomic variations. Cytokine, 76(2), 519–526. doi: 10.1016/j.cyto.2015.07.015.
  31. Molloy, T., Wang, Y., & Murrell, G. A. C. (2003). The roles of growth factors in tendon and ligament healing. Sports Medicine, 33(5), 381–394. doi: 10.2165/00007256-200333050-00004.
  32. Paradowska-Gorycka, A., Pawlik, A., Romanowska-Prochnicka, K., Haladyj, E., Malinowski, D., Stypinska, B., Manczak, M., & Olesinska, M. (2016). Relationship between VEGF gene polymorphisms and serum VEGF protein levels in patients with rheumatoid arthritis. Plos One, 11(8), e0160769. doi: 10.1371/journal.pone.0160769.
  33. Patel, S., & Varley, I. (2019). Exploring the regulation of genetic testing in sport. Entertainment and Sports Law Journal, 17(1), 5. doi: 10.16997/eslj.223.
  34. Pickering, C., Kiely, J., Grgic, J., Lucia, A., & Del Coso, J. (2019). Can genetic testing identify talent for sport? Genes, 10(12), 12. doi: 10.3390/genes10120972.
  35. Rahim, M., Gibbon, A., Hobbs, H., van der Merwe, W., Posthumus, M., Collins, M., & September, A. (2014). The association of genes involved in the angiogenesis-associated signaling pathway with risk of anterior cruciate ligament rupture. Journal of Orthopaedic Research, 32(12), 1612–1618. doi: 10.1002/jor.22705.
  36. Rahim, M., Hobbs, H., Van Der Merwe, W., Posthumus, M., Collins, M., & September, A. V. (2018). Investigation of angiogenesis genes with anterior cruciate ligament rupture risk in a South African population. Journal of Sports Sciences, 36(5), 551–557. doi: 10.1080/02640414.2017.1322710.
  37. Rahim, M., Lacerda, M., Collins, M., Posthumus, M., & September, A. V. (2022). Risk modelling further implicates the angiogenesis pathway in anterior cruciate ligament ruptures. European Journal of Sport Science, 22(4), 650–657. doi: 10.1080/17461391.2021.1884750.
  38. Rivron, N. C., Vrij, E. J., Rouwkema, J., Le Gac, S., Van Den Berg, A., Truckenmüller, R. K., & Van Blitterswijk, C. A. (2012). Tissue deformation spatially modulates VEGF signaling and angiogenesis. Proceedings of the National Academy of Sciences, 109(18), 6886–6891. doi: 10.1073/pnas.1201626109.
  39. Roth, S. M. (2012). Critical overview of applications of genetic testing in sport talent identification. Recent Patents on DNA & Gene Sequences, 6(3), 247–255. doi: 10.2174/187221512802717402.
  40. Shastry, B. S. (2009). SNPs: Impact on gene function and phenotype. In A. A. Komar (Ed.), Single nucleotide polymorphisms: Methods and protocols (pp. 3–22). Humana Press. doi: 10.1007/978-1-60327-411-1_1.
  41. Shibuya, M. (2011). Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes & Cancer, 2(12), 1097–1105. doi: 10.1177/1947601911423031.
  42. Shukla, M., Gupta, R., Pandey, V., Rochette, J., Dhandapany, P. S., Tiwari, P. K., & Amrathlal, R. S. (2020). VEGFA promoter polymorphisms rs699947 and rs35569394 are associated with the risk of anterior cruciate ligament ruptures among Indian athletes: A cross-sectional study. Orthopaedic Journal of Sports Medicine, 8(12), 2325967120964472. doi: 10.1177/2325967120964472.
  43. Stevens, A., Soden, J., Brenchley, P. E., Ralph, S., & Ray, D. W. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter1. Cancer Research, 63(4), 812–816.
  44. Takahashi, H., & Shibuya, M. (2005). The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science, 109(3), 227–241. doi: 10.1042/CS20040370.
  45. Ysabel, T., Spiteri, T., Hart, N. H., & Anderton, R. S. (2018). The potential role of genetic markers in talent identification and athlete assessment in elite sport. Sports, 6(3), 3. doi: 10.3390/sports6030088.
Language: English
Page range: 125 - 137
Submitted on: Nov 3, 2025
Accepted on: Mar 30, 2026
Published on: May 6, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Karolina Jabłońska-Paszko, Katarzyna Krawczak-Wójcik, Ewelina Maculewicz, published by University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.